Bilgetekin, I. Et Al. 2017. Antiangiogenic therapy in ovarian cancer – for whom and when?. Current Gynecologic Oncology .

Bilgetekin, I., ÇETİN, B., & ÖZET, A., (2017). Antiangiogenic therapy in ovarian cancer – for whom and when?. Current Gynecologic Oncology .

Bilgetekin, Irem, BÜLENT ÇETİN, And AHMET ÖZET. "Antiangiogenic therapy in ovarian cancer – for whom and when?," Current Gynecologic Oncology , 2017

Bilgetekin, Irem Et Al. "Antiangiogenic therapy in ovarian cancer – for whom and when?." Current Gynecologic Oncology , 2017

Bilgetekin, I. ÇETİN, B. And ÖZET, A. (2017) . "Antiangiogenic therapy in ovarian cancer – for whom and when?." Current Gynecologic Oncology .

@article{article, author={Irem Bilgetekin Et Al. }, title={Antiangiogenic therapy in ovarian cancer – for whom and when?}, journal={Current Gynecologic Oncology}, year=2017}